Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

REMSleep Holdings, Inc. RMSL OTC

Other OTC • Healthcare • Medical - Devices • US • USD

SharesGrow Score
28/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

REMSleep Holdings, Inc. (RMSL) is a Medical - Devices company in the Healthcare sector, currently trading at $0.01. It has a SharesGrow Score of 27/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Financials: revenue is $117,185, -39.5%/yr average growth. Net income is $1M (loss), growing at +29.5%/yr. Net profit margin is -919.9% (negative). Gross margin is 15.4% (-7.1 pp trend).

Balance sheet: total debt is $25,574 against $336.7B equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 1.93 (strong liquidity). Debt-to-assets is 4.3%. Total assets: $591,697.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 58/100 (Partial), Past 0/100 (Fail), Health 67/100 (Partial), Moat 7/100 (Fail), Future ?/100 (Fail), Income 10/100 (Fail).

RMSL SharesGrow Score Overview

36/100
SharesGrow Score
Below average — proceed with caution
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 58/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 67/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 7/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — RMSL

—
VALUE N/A
N/A
No analyst coverage available for this stock.
~
GROWTH Partial
58/100
RMSL: -39.5%/yr revenue is, +29.5%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
~
HEALTH Partial
67/100
Balance sheet RMSL: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 1.93 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
7/100
RMSL: Gross margin is 15.4% (-7.1 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 7/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
✗
INCOME Fail
10/100
RMSL: Net profit margin is -919.9%. negative. Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range0.0012-0.015
Volume536.8K
Avg Volume (30D)3.31M
Market Cap$9.63M
Beta (1Y)0.90
Share Statistics
Shares Outstanding$1.48B
IPO Date2009-07-24
Employees2
CEOJeffrey Marshall
Financial Highlights & Ratios
Revenue (TTM)$117.19K
Gross Profit$18.04K
EBITDA$-861.01K
Net Income$-1.08M
Operating Income$-793.55K
Total Cash$463.34K
Total Debt$25.57K
Net Debt$-437.77K
Total Assets$591.7K
Price / Sales (P/S)82.14
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS75990A2006

Price Chart

Track all markets on TradingView
RMSL
REMSleep Holdings, Inc. ↗  ·  Other OTC
Healthcare • Medical - Devices
0.00 52WK RANGE 0.02

People Also View

ABT
ABT
Abbott Laboratories
$101.07
+0.38%
 AXGN
AXGN
AxoGen, Inc.
$34.46
+2.96%
 VMD
VMD
Viemed Healthcare, Inc.
$9.71
+0.21%
 MASS
MASS
908 Devices Inc.
$7.32
+1.67%
 APYX
APYX
Apyx Medical Corporation
$3.84
-1.03%
 LUCD
LUCD
Lucid Diagnostics Inc.
$1.35
+5.47%
 LNSR
LNSR
LENSAR, Inc.
$6.04
+2.03%
 ODYY
ODYY
Odyssey Group International, Inc.
$0.07
-8.42%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message